Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S031 - Surgical Complications

Saturday, February 17; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify complications in dermatologic surgery, laser, and cosmetic procedures.
  • Develop an approach to minimize and prevent surgical complications.
  • Design a strategy to manage surgical complications should they arise.

Description

Surgical complications are unavoidable, even in the most experienced hands. Physicians who perform cutaneous surgery should engage in practices that seek to prevent such complications from arising. However, dermatologic surgeons must be prepared to recognize and treat surgical complications in the event that they arise. Having a strategy to minimize the risk of suboptimal results stemming from complications is key. Experienced cutaneous surgeons will discuss the prevention, diagnosis, and management of complications that may occur when performing dermatologic surgery, laser surgery, and cosmetic procedures.

Disclosures

  • Bar, Anna A., MD: no financial relationships exist with commercial interests.
  • Brown, Mariah C., MD: no financial relationships exist with commercial interests.
  • Cohen, Joel Lee, MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); LEO Pharma, US – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sciton Inc. – C(H);
  • Council, Martha Laurin, MD: MDoutlook – C(H); Medline Industries, Inc. – C(H);
  • Fisher, Emily J., MD: no financial relationships exist with commercial interests.
  • Glaser, Dee Anna, MD: Allergan, Inc. – I(Grants/Research Funding), O(H); Dermira – A(H), I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H); Galderma Research & Development, LLC – I(Grants/Research Funding); Miramar Labs – C(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Unilever Home & Personal Care USA – A(H);
  • Grekin, Roy C., MD: no financial relationships exist with commercial interests.
  • Hurst, Eva A., MD: no financial relationships exist with commercial interests.
  • Neuhaus, Isaac M., MD: no financial relationships exist with commercial interests.
  • Rohrer, Thomas E., MD: Allergan, Inc. – I(Grants/Research Funding); Candela Corporation – A(H), SP(H); Medicis Pharmaceutical Corporation – SP(H); Merz Pharmaceuticals, LLC – I(H); Pulse Biosciences – A(H); Ulthera – I(H);
  • Thomas, Valencia D., MD: Genentech, Inc. – A(H);
Schedule
Saturday, February 17
1:00 PM
Dr. Hurst and Dr. Neuhaus / Introduction
1:05 PM
Dr. Rohrer / Laser Complications
1:25 PM
Dr. Glaser / Toxin Complications
1:45 PM
Dr. Cohen / Filler Complications
2:05 PM
/ Bleeding Complications
2:25 PM
Dr. Council / Infectious Complications
2:45 PM
Dr. Thomas / Free Margin Distortion
3:05 PM
Dr. Brown / Surgical Scar Revision
3:15 PM
Dr. Bar / Laser and Nonsurgical Scar Revision
3:25 PM
Dr. Grekin / The Difficult Patient
3:45 PM
All faculty / Question and Answer
Event Details
  • Date
    Saturday, February 17
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 26A
  • CME Credits
    3.00
  • Type
    Restricted
Directors/Co-Directors
  • Eva A. Hurst, MD, FAAD
  • Isaac M. Neuhaus, MD, FAAD
Speakers
  • Anna A. Bar, MD, FAAD
  • Dee Anna Glaser, MD, FAAD - Handout
  • Emily J. Fisher, MD, FAAD
  • Joel Lee Cohen, MD, FAAD - Handout
  • Mariah C. Brown, MD, FAAD
  • Martha Laurin Council, MD, FAAD
  • Roy C. Grekin, MD, FAAD
  • Thomas E. Rohrer, MD, FAAD
  • Valencia D. Thomas, MD, FAAD